The Japanese Biochemical Society/The Molecular Biology Society of Japan

10:40 AM - 10:50 AM

[2T18-11(2P0898)] Advanced hybridoma technology for the next generation of stereospecific therapeutic medicine.

〇Chiho Miyamae1, Yushi Isozaki1, Kanta Tsumoto1, Masahiro Tomita1 (1.Mol. Bioeng. Lab., Grad. Sch. Eng., Mie Univ.)

Cell-ELISA, DNA immunization, Hybridoma cell, Immunofluorescence analysis, Stereospecific monoclonal antibody

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password